Abstract
In this issue, Weber and coworkers report that DNA-demethylating drugs alter the transcriptional expression of the cMet proto-oncogene. Abnormal transcription is driven by the antisense promoter of a Line-1 repetitive element present within an intron. The element is a recent addition to the genome and is absent in animal models of cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Apostolou E, Thanos D . (2008). Virus infection induces NF-κB-dependent interchromosomal associations mediating monoallelic IFN-beta gene expression. Cell 134: 85–96.
Comfort NC . (2001). From controlling elements to transposons: Barbara McClintock and the Nobel Prize. Endeavour 25: 127–130.
Faulkner GJ, Kimura Y, Daub CO, Wani S, Plessy C, Irvine KM et al. (2009). The regulated retrotransposon transcriptome of mammalian cells. Nat Genet 41: 563–571.
Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D et al. (2010). Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16: 571–579.
Penzkofer T, Dandekar T, Zemojtel T . (2005). L1Base: from functional annotation to prediction of active LINE-1 elements. Nucleic Acids Res 33 (Database issue): D498–D500.
Rangwala SH, Zhang L, Kazazian Jr HH . (2009). Many LINE1 elements contribute to the transcriptome of human somatic cells. Genome Biol 10: R100.
Roman-Gomez J, Jimenez-Velasco A, Agirre X, Cervantes F, Sanchez J, Garate L et al. (2005). Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene 24: 7213–7223.
Saito Y, Suzuki H, Tsugawa H, Nakagawa I, Matsuzaki J, Kanai Y et al. (2009). Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 28: 2738–2744.
Speek M . (2001). Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes. Mol Cell Biol 21: 1973–1985.
Szpakowski S, Sun X, Lage JM, Dyer A, Rubinstein J, Kowalski D et al. (2009). Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene 448: 151–167.
Weber B, Kimhi S, Howared G, Eden A, Lyko F . (2010). Demethylation of a LINE-1 antisense promoter in the cMet locus impairs Met signaling through induction of illegitimate transcription. Oncogene 29: 5775–5784.
Wolff EM, Byun HM, Han HF, Sharma S, Nichols PW, Siegmund KD et al. (2010). Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6: e1000917.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no conflict of interest.
Rights and permissions
About this article
Cite this article
Lizardi, P. As we bring demethylating drugs to the clinic, we better know the DICE being cast. Oncogene 29, 5772–5774 (2010). https://doi.org/10.1038/onc.2010.372
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.372
This article is cited by
-
Epigenetic cancer therapy: rationales, targets and drugs
Oncogene (2012)